SUBSTITUTED 4-[5-(BENZOFURAN-2-YL)-1,2,4-OXADIAZOL-3-YL]BENZOIC ACID COMPOUNDS FOR USE IN THERAPY FOR NEUROPATHIC PAIN

The present invention pertains generally to the field of therapy. More specifically, the present invention pertains to certain substituted 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoic acid compounds (collectively referred to herein as BOBA compounds), and pharmaceutical compositions comprisin...

Full description

Saved in:
Bibliographic Details
Main Authors CORCORAN, JONATHAN PATRICK THOMAS, DE CASTRO VASCONCELOS GONCALVES, MARIA BEATRIZ
Format Patent
LanguageEnglish
French
Published 03.12.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention pertains generally to the field of therapy. More specifically, the present invention pertains to certain substituted 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoic acid compounds (collectively referred to herein as BOBA compounds), and pharmaceutical compositions comprising those compounds, for use in a method of treatment or prevention of neuropathic pain. (Formula (A)) La présente invention concerne de manière générale le domaine thérapeutique. Plus spécifiquement, la présente invention concerne certains composés d'acide 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoïque substitué (désignés collectivement ici en tant que composés BOBA), et des compositions pharmaceutiques comprenant ces composés, pour utilisation dans une méthode de traitement ou de prévention de la douleur neuropathique. (Formule (A))
Bibliography:Application Number: CA20203139239